Clinical trials
Shock, Septic trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2017 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 3 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amsterdam UMC, location VUmc | 3 |
| Frisius Medisch Centrum | 2 |
| Radboud University Medical Center | 2 |
| A.P.J. Vlaar | 1 |
| Adrenomed AG | 1 |
| Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) | 1 |
| Catharina Ziekenhuis Eindhoven | 1 |
| Danish Procalcitonin Study Group | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Septic | 24 |
| Sepsis | 17 |
| Critical Illness | 5 |
| Infections | 3 |
| Acute Kidney Injury | 2 |
| Bacterial Infections | 2 |
| Shock, Cardiogenic | 2 |
| Adrenal Insufficiency | 1 |
| Emergencies | 1 |
| Heart Diseases | 1 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.